Stock listing
Level Bio Ab
Selected listing: LEVBIO · NGM · SEK · SE
Level Bio Ab (NGM:LEVBIO), Distribution Services. Latest release Apr 23, 2026: LEVBIO: 15% sales growth and CyberGene divestment signal a strategic focus…
- Ticker
- NGM:LEVBIO
- Asset type
- Stock
- Sector
- Distribution Services
- Industry
- Medical Distributors
- Exchange
- NGM
- Currency
- SEK
About Level Bio Ab
Level Bio Ab is a public company listed on the Swedish market under the ticker LEVBIO. Level Bio Ab focuses on developing innovative solutions in the biotechnology sector.
Latest news from Level Bio Ab
LEVBIO: 15% sales growth and CyberGene divestment signal a strategic focus on diagnostics distribution
April 23, 2026
LEVBIO: 29% sales growth and improved results, but future revenue to decline after CyberGene sale
February 19, 2026
LEVBIO: Q3 2025 saw 5% revenue growth, higher margins, and improved cash flow amid Nordic expansion
October 23, 2025
LEVBIO: Platform upgrades, Q4 pilot, and lab partnerships drive ongoing business development
August 21, 2025
LEVBIO: Nordic market growth surged 44% year-over-year, fueled by rebranding and tech advances
April 24, 2025